Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

595 trials

NCT07052916
Recruiting
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Not applicable · United States · 7 sites
Registry update: 26 May 2026
NCT07085559
Recruiting
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Early phase 1 · China · 1 site
Registry update: 25 Jul 2025
2024-517325-43-00
Recruiting
IFM2024-06 : A multi-center, open-label, phase 2 randomized study of elranatamab plus lenalidomide versus daratumumab plus lenalidomide as post transplantation maintenance therapy in patients with newly-diagnosed myeloma
Phase 2 · France · 38 sites
Registry update: 10 Jul 2026
NCT07014865
Recruiting
Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers
Not applicable · Italy · 1 site
Registry update: 29 Aug 2025
NCT06461988
Recruiting
Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma
Phase 2 · United States · 1 site
Registry update: 17 Jul 2026
NCT06762769
Recruiting
Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Phase 2 · United Kingdom · 14 sites
Registry update: 20 Oct 2026
NCT07268846
Recruiting
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery
Not applicable · Brazil · 1 site
Registry update: 8 Dec 2025
NCT06947083
Recruiting
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
Phase 2 · United States · 1 site
Registry update: 3 Dec 2025
NCT07003568
Recruiting
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Phase 1 · China · 1 site
Registry update: 26 Nov 2025
NCT07003555
Recruiting
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Phase 1 · China · 1 site
Registry update: 26 Nov 2025
2024-519498-20-00
Recruiting
A first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, bone marrow, lymph and lymphatic system.
Phase 1/2 · Spain · 11 sites
Registry update: 5 Nov 2026
NCT06976476
Recruiting
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Phase 2 · United States · 9 sites
Registry update: 5 Oct 2026
NCT07202078
Recruiting
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/3 · Australia · 3 sites
Registry update: 7 Oct 2025
NCT06976437
Recruiting
A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors
Early phase 1 · China · 1 site
Registry update: 10 Jul 2025
NCT07202052
Recruiting
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/3 · Australia · 3 sites
Registry update: 7 Oct 2025
NCT07202091
Recruiting
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Phase 2/3 · Australia · 3 sites
Registry update: 7 Oct 2025
NCT06627751
Recruiting
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Phase 2 · United States · 1 site
Registry update: 18 Aug 2026
NCT07032129
Recruiting
Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma
Phase 1/2 · China · 1 site
Registry update: 22 Jun 2025
NCT06960993
Recruiting
Mosaic Trial for Stem Cell Transplant Recipients
Not applicable · United States · 3 sites
Registry update: 30 Oct 2026
NCT07202065
Recruiting
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/3 · Australia · 3 sites
Registry update: 7 Oct 2025

Ordered by registry start date. Freshness and sponsorship never change the order.